Delaying b-cell depleters (Ocrevus, kesimpta, rituximab) increases the chance of getting protective antibodies after covid-19 vaccination
Delaying b-cell depleters (Ocrevus, kesimpta, rituximab) increases the chance of getting protective antibodies after covid-19 vaccination
source http://hub.page/physical-disorders/delaying-bcell-depleters-ocrevus-kesimpta-rituximab-increases-the-chance-of-getting-protective-antibodies-after-covid19-vaccination-
source https://hubpage1.tumblr.com/post/674018961038409728
https://newsandnews1.wordpress.com/2022/01/22/delaying-b-cell-depleters-ocrevus-kesimpta-rituximab-increases-the-chance-of-getting-protective-antibodies-after-covid-19-vaccination/